Filtered By:
Specialty: Allergy & Immunology
Vaccination: Vaccines

This page shows you your search results in order of date.

Order by Relevance | Date

Total 422 results found since Jan 2013.

Association of Guillain-Barr é syndrome following COVID-19 vaccination
Conclusion: This review highlights the diverse and clinically relevant associations between COVID-19 vaccination and GBS. The findings underscore the importance of conducting further studies to explore the causative links in this correlation and gain a better understanding of the relationship.PMID:37681361 | DOI:10.1177/03946320231199349
Source: International Journal of Immunopathology and Pharmacology - September 8, 2023 Category: Allergy & Immunology Authors: Selia Chowdhury Samia Chowdhury Source Type: research

Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis
ConclusionThe seroconversion rate in LTR vaccinated with at least two doses of mRNA COVID-19 vaccine could be significantly affected by the vaccine type, immunosuppressant used, BMI, leukopenia, associated comorbidities, and time since transplantation. Nevertheless, booster doses are still recommended for LTR.
Source: Frontiers in Immunology - September 5, 2023 Category: Allergy & Immunology Source Type: research

Immunogenicity and safety of Havisure < sup > TM < /sup > vaccine developed by Human Biologicals Institute in healthy subjects of 12  months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
CONCLUSION: The study results indicate that the Havisure™ vaccine is immunogenic and safe when administered to healthy subjects of 12 months to 49 years of age, and is non-inferior to Havrix® Vaccine.PMID:37661535 | DOI:10.1016/j.vaccine.2023.08.084
Source: Vaccine - September 4, 2023 Category: Allergy & Immunology Authors: Sai Krishna Susarla Madhu Gupta Kheya Ghosh Uttam Sonali Palkar Ashish Ramachandra Dhongade K Siva Ram Prasad Vasudev Rajapantula M D Ravi N Pradeep M Satish B C Rajashakar G Sandhya L Rajendra Devi Prasad Sahoo Anand Kumar Kanakasapapathy Source Type: research

Immunogenicity and safety of Mebella ™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study
CONCLUSION: It was concluded from the study results that the test vaccine, Mebella™, was immunogenic and well tolerated and was non-inferior to the comparator vaccine, MR-VAC®, when administered to healthy subjects of 9 months to 49 years of age. Clinical Trial Registry of India Identifier: CTRI/2020/07/026930.PMID:37659893 | DOI:10.1016/j.vaccine.2023.08.065
Source: Vaccine - September 2, 2023 Category: Allergy & Immunology Authors: Sai Krishna Susarla Rahul Jahagirdar Kheya Ghosh Uttam S Srikanth Bhatt S Prashanth Vasudev Rajapantula M Satish B C Rajashakar G Sandhya L Rajendra Devi Prasad Sahoo Anand Kumar Kanakasapapathy Source Type: research

The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers
CONCLUSIONS: The prevalence of SIRVA is estimated at 3% in the adult working population. Signs and symptoms of SIRVA are variable in severity, localization and timing. Soft-tissue abnormalities is the most common clinical sign. This study contributes to clinician's knowledge on SIRVA, aiding in early recognition and treatment, which are imperative for prevention of persistent and severe shoulder pathology.PMID:37635003 | DOI:10.1016/j.vaccine.2023.08.043
Source: Vaccine - August 27, 2023 Category: Allergy & Immunology Authors: Esther R C Janssen Astrid Z van Montfoort Freek Hollman Frederik O Lambers Heerspink Source Type: research

Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population
CONCLUSIONS: Some adverse reactions to the COVID-19 vaccination are a greater risk of symptoms in the younger group, women, and participants with lower BMI. Care should be taken to monitor women, younger people, and individuals with a low body mass index for adverse effects after receiving the COVID-19 vaccination.PMID:37455163 | DOI:10.1016/j.vaccine.2023.04.053
Source: Vaccine - July 16, 2023 Category: Allergy & Immunology Authors: Xi Lu Shota Masuda Hasita Horlad Takahiko Katoh Source Type: research

Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination
CONCLUSION: Menstrual disturbances were common regardless of vaccination. We found increased risk of menstrual disturbances after vaccination, particularly for heavier bleeding than usual, prolonged bleeding, shorter interval between menstruations, and stronger period pain. In the future, menstrual characteristics should be included in vaccine trials.PMID:37451876 | DOI:10.1016/j.vaccine.2023.06.088
Source: Vaccine - July 14, 2023 Category: Allergy & Immunology Authors: Lill Trogstad Ida Laake Anna H Robertson Siri Mjaaland Ida H Caspersen Lene K Juvet Per Magnus Kristine Blix Berit Feiring Source Type: research

Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens
CONCLUSION: The frequency of immediate adverse reactions was highest among females and younger persons, however, most of the Danish citizens did not experience immediate adverse reactions following COVID-19 vaccination.PMID:37391313 | PMC:PMC10288319 | DOI:10.1016/j.vaccine.2023.06.069
Source: Vaccine - June 30, 2023 Category: Allergy & Immunology Authors: K Torp Hansen F Kusk Povlsen B Hammer Bech S Nygaard Hansen C Ulrikka Rask P Fink T J ørgensen H Nielsen T Meinertz Dantoft S Marie Thysen D Rytter Source Type: research

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022
CONCLUSION: Our review confirmed previously established safety risks for TTS and GBS and identified a potential safety concern for myocarditis.PMID:37321898 | DOI:10.1016/j.vaccine.2023.06.023
Source: Vaccine - June 15, 2023 Category: Allergy & Immunology Authors: Emily Jane Woo Julianne Gee Paige Marquez James Baggs Winston E Abara Michael M McNeil Rositsa B Dimova John R Su Source Type: research